The Canadian Nephrology Trials Network (CNTN) is excited to be part of the upcoming Canadian Society of Nephrology AGM pre-course in Vancouver. Join us for the CNTN Research Symposium on Wednesday, May 7, 2025 (7:30 – 11:30 a.m. PST) to hear research updates, learn what’s ahead for CNTN and how to get involved.
Don’t forget to stop by the Can-SOLVE CKD/CNTN booth and get some CNTN promotional material.
The hybrid event is open for registration and there are 10 more in-person spots available – make sure to register today!
There will be presentations from:
- Dr. Adeera Levin – EASI-Kidney: A multicenter international randomized double-blind placebo-controlled clinical trial in patients with chronic kidney disease.
- Vikas Sridhar on behalf of Dr. David Cherney – Sugar & Salt: The Sodium Glucose Co-Transport-2 Inhibition Diabetes and Kidney Function Loss in Type 1 Diabetes (SUGARNSALT) research project.
- Dr. Thomas Mavrakanas – CARe-MRI clinical trial: Canagliflozin in advanced renal disease with MRI endpoints.
- Dr. Istvan Mucsi – PROMS: Feasibility pilot study to use Patient Reported Outcome Measures (PROMs) for symptom assessment and management in patients on dialysis.
- Dr. John Gill – PART: Prevention of Allosensitization in Renal Transplant Candidates
If you have questions please contact Omo Enilama at oenilama@cansolveckd.ca